Abstract: Non-availability 
Introduction
Aerobic Gram negative bacilli are common agents of infection in hospitalized patients. They are the cause for community and hospital acquired bacteremia, and the majority of cases of hospital acquired pneumonia, both being severe infections associated with a high mortality. The outcome of severe infections caused by aerobic Gram negative bacilli may depend on rapid and appropriate therapy 1, 2 . The Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility testing can be considered the major international contribution to antimicrobial susceptibility testing 3 .
The main difference between EUCAST and CLSI is the elimination, or at least a reduction of the intermediate AST category. EUCAST has removed the intermediate zone. Consequently, AST reports are simplified by reporting an isolate as either susceptible or resistant. This strategy will change AST reports, mostly by reporting isolates as resistant that were formerly considered intermediate 4 . This study aimed at comparing AST done according to CLSI and EUCAST guidelines for Gram negative bacilli using Cefotaxime, Ceftazidime, Piperacillin/Tazobactam and Nitrofurantoin antibiotic discs. The results of this study will support clinical microbiological laboratories in correct interpretation and antibiotic therapy recommendations to clinicians during the transition phase from the CLSI system to EUCAST system. Close interaction with and information from clinicians is needed to avoid uncertainities in the interpretation of changes in AST reports 4 .
II. Methods Clinical isolates : A total of 100 clinical isolates of Gram negative bacilli were included in the study. The 100 clinical isolates comprised of 73 Enterobacteriaceae ( 31 Escherichia coli, 35 Klebsiella species, 7 Proteus species) and 27 Pseudomonas species.
Susceptibility testing : Antibiotic susceptibility testing was performed by the disk diffusion method, with Mueller-Hinton agar, according to CLSI and EUCAST methodology 5 . The plates were inoculated with samples of each strain adjusted to a turbidity of 0.5Mc Farland. The discs were applied to the surface of inoculated plates and the plates were incubated for 20 hours at 37°c [4] [5] [6] [7] When the inhibitory zone edge is heaped or colonies are growing within the inhibition zone, the particular drug is reported as resistant. Thus, zone edge quality was also taken into account 8 . (fig 1,2 Besides the national AST systems (e.g in Germany, France, UK and Sweden), many laboratories, particularly in countries without a rational AST system, have been using CLSI guidelines for many years 4 . Many European laboratories are currently prepared to implement the new EUCAST guidelines for AST.
Limitations of EUCAST:
1. Implementation of EUCAST guidelines will affect antibiotic prescription, in part because of the partial elimination of the intermediate category. Defining isolates as resistant that were formerly considered intermediate will most likely lead clinicians to use other antimicrobial classes 4 . 2. The number of useful antimicrobial treatment options for Gram negative bacilli like Enterobacteriaceae and glucose non-fermenting GNB like pseudomonas will probably decrease after implementation of EUCAST guidelines due to higher resistance rates. The choice of drugs available to the clinician is limited 4 . 3. More Gram negative bacilli will be reported as multidrug resistant, resulting in higher rates of patients in isolation and concomitantly higher costs. A higher rate of multidrug-resistant Gram negative bacilli will not only result in higher costs for hospitals and hospital hygiene measures, but will also result in more confirmatory testing in the laboratory 4 . Comparision of AST done by CLSI and EUCAST was done by Michael Hombach, Guido V. Bloemberg, Erik C. Bottger et al., by using antibiotics discs with same concentration as per CLSI and EUCAST. Higher resistance rate was reported by following EUCAST guidelines as the intermediate category drugs were reported as resistant. Their study did not include cefotaxime, ceftazidime, piperacillin tazobactam and nitrofurantoin as they differ in antibiotic disc concentration as per CLSI and EUCAST 4 . Though, discs with different concentrations were included in our study, we found that the inhibitory zone diameters were almost similar and the resistance rates were higher as per EUCAST than CLSI. These results correlated with the work done by Michael Hombach, Guido V. Bloemberg, Erik C. Bottger et al.,
CLSI documents are not freely available. There is also some degree of confusion to the clinician 1 , as for the drugs reported as intermediate susceptible, the clinician uses higher concentration of drugs. Moreover the success of therapy is not predictable.
Whereas EUCAST documents are freely available on net making them feasible for the microbiologist to implement. Implementation of these guidelines gives a clear picture to the clinician as intermediate category is eliminated and only susceptibility and resistance are reported. Implementation of EUCAST standards for antibiotic susceptibility testing made results in Europe more comparable, incorporating PK-PD studies and clinical data 1 . E. Matuschek, D. F. J. Brown and G. Kahlmeter expressed that EUCAST encourages laboratories with expertise in susceptibility testing to participate in a network of collaborating laboratories interested in contributing to the development and maintainance of the disk diffusion test. With this network, the future of the EUCAST disk diffusion method is secured. Automated susceptibility testing may relieve laboratories of some AST work, but their lack of versatility, the unavailability of some agents and tests for some species, and their long development times, still favour the use of disk diffusion testing for many years to come 5 . 
V. Conclusion
From the observations of our study, we conclude that antibiotic susceptibility testing by EUCAST guidelines is more feasible than CLSI guidelines to both the microbiologist and the clinician. Advantages though less, outweigh the disadvantages as it helps in specific reporting of sensitivity.
